The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rybelsus



Novo Nordisk A/SEU/1/20/1430/005-007

Main Information

Trade NameRybelsus
Active Substancessemaglutide
Dosage FormTablet
Licence HolderNovo Nordisk A/S
Licence NumberEU/1/20/1430/005-007

Group Information

ATC CodeA10BJ06 semaglutide

Status

License statusAuthorised
Licence Issued03/04/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back